Search

Your search keyword '"Martinetti, G."' showing total 253 results

Search Constraints

Start Over You searched for: Author "Martinetti, G." Remove constraint Author: "Martinetti, G."
253 results on '"Martinetti, G."'

Search Results

1. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

2. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

3. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

4. Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study

5. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

6. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study

7. Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships

8. Ethnicity predicts viral rebound after travel to the tropics in HIV‐infected travelers to the tropics in the Swiss HIV Cohort Study

9. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017

10. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

11. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

12. A highly virulent variant of HIV-1 circulating in the Netherlands

13. Children living with HIV in Europe: do migrants have worse treatment outcomes?

14. Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study

15. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

16. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study

17. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

18. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

19. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

20. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

21. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection

22. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

23. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

24. Ageing with HIV: medication use and risk for potential drug–drug interactions

26. Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

27. Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand

28. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

29. Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection

30. Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV

31. The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals

32. Ageing with HIV: medication use and risk for potential drug-drug interactions

33. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

34. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012

35. Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide

36. Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study

38. Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population

39. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients

40. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

41. Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

42. New subcluster of HEV genotype 3 strains linked to the first confirmed Swiss case of foodborne hepatitis E infection

43. Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

44. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study

45. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

46. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

47. Increases in Condomless Sex in the Swiss HIV Cohort Study

48. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

49. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

50. Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013

Catalog

Books, media, physical & digital resources